Pfizer says COVID pill cuts risk of hospitalization, death by 89 percent

Pharmaceutical giant Pfizer announced Friday that its antiviral COVID-19 pill, when administered in conjunction with a widely used HIV drug, cut the risk of hospitalization or death by 89 percent in virus patients. The preliminary results from the trial were so positive that an independent board of experts recommended that the study be halted so that the drug can be offered to the general public sooner, the drugmaker said.rom the trial were so positive that an independent board of experts recommended that the study be halted so that the drug can be offered to the general public sooner, the drugmaker said.-- More...